Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.03, in-line with the analyst estimate of $5.03. Revenue for the quarter came in at $10.71 billion versus the consensus estimate of $10.65 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.